Head and Neck Cancer
Back to Oncology/Cancer Clinical Trials Main PageCPMC Cancer Services
| Principal Investigator/Contact Information | Protocol Title | Patient Population | Recruitment Period |
| Principal Investigator: CPMC Oncologists Contact: Brenda Eng 415-600-1775 | A Randomized Phase III Trial Of Concurrent Accelerated Radiation And Cisplatin Versus Concurrent Accelerated Radiation, Cisplatin, And Cetuximab (C225) [Followed By Surgery For Selected Patients] For Stage III And IV Head And Neck Carcinomas. RTOG 0522 Visit this study on ClinicalTrials.gov. | Subjects with Stage III and IV head and neck cancer | Open |
Updated: 11/13/09
Back to top

